← All organizations
Highest phase reached
Phase 2
First clinical trial
Aug 31, 2019Last known activity
Mar 14, 2024
Timeline
No events for the selected filters.
Drugs by trial phase (4 distinct, 4 trials)
Phase 2 (1 own, 0 via acquisition)
Phase 1 (3 own, 0 via acquisition)
Indications
Recent trials (4)
- NCT06727630Lead sponsorPhase 1/Phase 2Mar 14, 2024
- NCT05315167Lead sponsorPhase 1/Phase 2May 30, 2022
- NCT05159700Lead sponsorPhase 1Feb 28, 2022
- NCT04037566CollaboratorPhase 1Aug 31, 2019
Details
- Last known activity
- Mar 14, 2024